Composition for treating lung cancer and application in preparing medicine for treating lung cancer

Abstract

The invention discloses a composition for treating a lung cancer and an application in preparing a medicine for treating the lung cancer. The composition comprises the following ingredients in effective treatment doses: any one or two of radix ranunculi ternati and selfheal, any one or two of bombyx batryticatus and gecko, any one or two of glabrous sarcandra herb and solani nigri herba, any one or two of edible tulip and sculellaria barbata, any one or two of thunberg fritillary and northern apricot kernel, ganoderma lucidum, any one or two of rhizoma pinellinae praeparata and tangerine peel and any one or two of American ginseng and codonopsis pilosula. The composition is provided in an ingredient proportion lower than a toxic dose. The composition can be further combined with a chemotherapeutant or a target medicine for use. According to the composition and the application, relevant symptoms of the lung cancer can be effectively improved; the tumor progression is retarded; the tumor medicine resistance is antagonized; toxic and side effects of chemotherapy are relieved, so that the life quality of a patient with the advanced lung cancer is improved; life benefits are brought to the patient with the lung cancer; the curative effect is exact and objective.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a traditional Chinese medicine composition for treating lung cancer with traditional Chinese animal and plant medicines as raw materials, and its application for preparing medicines for treating lung cancer. Background technique [0002] Primary bronchial lung cancer is one of the malignant tumors with the highest incidence in the world, and its morbidity and mortality are still increasing year by year, seriously threatening human health and life. The morbidity and mortality of lung cancer in my country ranks first among malignant tumors among men, and second only to breast cancer among women. According to the statistics of the World Health Organization in 2005, there are 1.35 million new cases of lung cancer in the world every year, accounting for 12.4% of all malignant tumors, and 118,000 deaths, accounting for 17.6% of all tumor deaths. Among them, there are about 500,000 new cases of...

AI Technical Summary

Problems solved by technology

But as far as the current situation is concerned, the anti-tumor research direction of traditional Chinese medicine is mainly concentrated on the treatment of Western medicine, and Chinese medicine is combined with radiotherapy and chemotherapy to reduce its toxic and side effects. Research from the perspective of stabilizing tumor size, delaying drug resistance, and prolonging patient survival

At the same time, there is a lack of basic pharmacological research and prospective comparative studies in the research on the treatment of lung cancer with integrated traditional Chinese and Western medicine. The mechanism of action is unclear and the research results are not convincing.

In addition, there are not many collaborative researches conducted by various units and centers, the standards of diagnosis and treatment are not uniform enough, and the samples of clinical observation cases are relatively small, lacking statistical significance

Some studies did not set up a strict control group, and the research results lacked evidence-based medical evidence, which seriously affected the promotion of traditional Chinese medicine in tumor treatment

Images